Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 370

1.

MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene.

Ohuchida K, Mizumoto K, Lin C, Yamaguchi H, Ohtsuka T, Sato N, Toma H, Nakamura M, Nagai E, Hashizume M, Tanaka M.

Ann Surg Oncol. 2012 Jul;19(7):2394-402. doi: 10.1245/s10434-012-2252-3. Epub 2012 Mar 10.

PMID:
22407312
2.

MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.

Yu J, Ohuchida K, Mizumoto K, Fujita H, Nakata K, Tanaka M.

Cancer Biol Ther. 2010 Oct 15;10(8):748-57. doi: 10.4161/cbt.10.8.13083. Epub 2010 Oct 15.

PMID:
20703102
3.

MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis.

Nakata K, Ohuchida K, Mizumoto K, Kayashima T, Ikenaga N, Sakai H, Lin C, Fujita H, Otsuka T, Aishima S, Nagai E, Oda Y, Tanaka M.

Surgery. 2011 Nov;150(5):916-22. doi: 10.1016/j.surg.2011.06.017.

PMID:
22018284
4.

Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer.

Weiss FU, Marques IJ, Woltering JM, Vlecken DH, Aghdassi A, Partecke LI, Heidecke CD, Lerch MM, Bagowski CP.

Gastroenterology. 2009 Dec;137(6):2136-45.e1-7. doi: 10.1053/j.gastro.2009.08.065. Epub 2009 Sep 10.

PMID:
19747919
5.

Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma.

Liu Q, Chen J, Wang J, Amos C, Killary AM, Sen S, Wei C, Frazier ML.

Mol Carcinog. 2014 Sep;53(9):711-21. doi: 10.1002/mc.22023. Epub 2013 May 9.

6.

Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development.

Zhang S, Hao J, Xie F, Hu X, Liu C, Tong J, Zhou J, Wu J, Shao C.

Carcinogenesis. 2011 Aug;32(8):1183-9. doi: 10.1093/carcin/bgr105. Epub 2011 Jun 10.

7.

Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.

Mees ST, Mardin WA, Sielker S, Willscher E, Senninger N, Schleicher C, Colombo-Benkmann M, Haier J.

Ann Surg Oncol. 2009 Aug;16(8):2339-50. doi: 10.1245/s10434-009-0531-4. Epub 2009 May 28.

PMID:
19475450
8.

MicroRNA expression profiles and miR-10a target in anti-benzo[a] pyrene-7, 8-diol-9, 10-epoxide-transformed human 16HBE cells.

Shen YL, Jiang YG, Greenlee AR, Zhou LL, Liu LH.

Biomed Environ Sci. 2009 Feb;22(1):14-21. doi: 10.1016/S0895-3988(09)60016-7.

PMID:
19462682
9.

Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells.

Bao B, Wang Z, Ali S, Ahmad A, Azmi AS, Sarkar SH, Banerjee S, Kong D, Li Y, Thakur S, Sarkar FH.

Cancer Prev Res (Phila). 2012 Mar;5(3):355-64. doi: 10.1158/1940-6207.CAPR-11-0299. Epub 2011 Nov 15.

10.

Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma.

Nagao Y, Hisaoka M, Matsuyama A, Kanemitsu S, Hamada T, Fukuyama T, Nakano R, Uchiyama A, Kawamoto M, Yamaguchi K, Hashimoto H.

Mod Pathol. 2012 Jan;25(1):112-21. doi: 10.1038/modpathol.2011.142. Epub 2011 Oct 7.

11.

LIM only 4 is overexpressed in late stage pancreas cancer.

Yu J, Ohuchida K, Nakata K, Mizumoto K, Cui L, Fujita H, Yamaguchi H, Egami T, Kitada H, Tanaka M.

Mol Cancer. 2008 Dec 22;7:93. doi: 10.1186/1476-4598-7-93.

12.

MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions.

du Rieu MC, Torrisani J, Selves J, Al Saati T, Souque A, Dufresne M, Tsongalis GJ, Suriawinata AA, Carrère N, Buscail L, Cordelier P.

Clin Chem. 2010 Apr;56(4):603-12. doi: 10.1373/clinchem.2009.137364. Epub 2010 Jan 21.

13.

MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis.

Hou Z, Xie L, Yu L, Qian X, Liu B.

Med Oncol. 2012 Jun;29(2):886-92. doi: 10.1007/s12032-011-9862-7. Epub 2011 Feb 24.

PMID:
21347720
14.

MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma.

Ikenaga N, Ohuchida K, Mizumoto K, Yu J, Kayashima T, Sakai H, Fujita H, Nakata K, Tanaka M.

Ann Surg Oncol. 2010 Dec;17(12):3120-8. doi: 10.1245/s10434-010-1188-8. Epub 2010 Jul 22.

PMID:
20652642
15.

The clinical significance and regulation mechanism of hypoxia-inducible factor-1 and miR-191 expression in pancreatic cancer.

Song Z, Ren H, Gao S, Zhao X, Zhang H, Hao J.

Tumour Biol. 2014 Nov;35(11):11319-28. doi: 10.1007/s13277-014-2452-5. Epub 2014 Aug 14.

PMID:
25119596
16.

MicroRNA-138-5p regulates pancreatic cancer cell growth through targeting FOXC1.

Yu C, Wang M, Li Z, Xiao J, Peng F, Guo X, Deng Y, Jiang J, Sun C.

Cell Oncol (Dordr). 2015 Jun;38(3):173-81. doi: 10.1007/s13402-014-0200-x. Epub 2015 Feb 10.

17.

Insig2 is overexpressed in pancreatic cancer and its expression is induced by hypoxia.

Kayashima T, Nakata K, Ohuchida K, Ueda J, Shirahane K, Fujita H, Cui L, Mizumoto K, Tanaka M.

Cancer Sci. 2011 Jun;102(6):1137-43. doi: 10.1111/j.1349-7006.2011.01936.x. Epub 2011 Apr 27.

18.

miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells.

Feng L, Xie Y, Zhang H, Wu Y.

Med Oncol. 2012 Jun;29(2):856-63. doi: 10.1007/s12032-011-9823-1. Epub 2011 Jan 25.

PMID:
21264532
19.

MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by targeting DVL2.

Zheng C, Yinghao S, Li J.

Med Oncol. 2012 Jun;29(2):815-22. doi: 10.1007/s12032-011-9934-8. Epub 2011 Apr 13.

PMID:
21487968
20.

MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9.

Hamada S, Satoh K, Fujibuchi W, Hirota M, Kanno A, Unno J, Masamune A, Kikuta K, Kume K, Shimosegawa T.

Mol Cancer Res. 2012 Jan;10(1):3-10. doi: 10.1158/1541-7786.MCR-11-0272. Epub 2011 Nov 7.

Items per page

Supplemental Content

Write to the Help Desk